← Company intelligence

Robot maker · early

Magnendo

Corporate marketmedicalCurated record

Magnendo is an MIT spinout developing a magnetic robotic navigation platform for neurovascular stroke intervention. Its core technology is a magnetically steerable soft-robotic guidewire paired with robotic actuation, real-time medical imaging integration, and intelligent navigation software that enables physicians to reach previously inaccessible vessels in the brain with reduced procedure time and lower perforation risk. The system targets endovascular thrombectomy and aneurysm access; first-in-human clinical studies are the immediate next milestone. CMO Aman B. Patel is Director of Endovascular Neurosurgery at Harvard/MGH.

HeadquartersNewton, US
Founded2024
Corporate funding$18M
TeamNot listed
Deployments0
Open roles0
01

Company overview

Identity and operating footprint

Company typeRobot maker
Market segmentCorporate
StageSeries A
FoundersYoonho Kim (Founder & CEO), Miki Rosenberg (Co-founder & CDO)
Regions servedNorth America
Countries deployedNot listed
Service footprintNot listed
Last reviewed2026-07-28
XNot listed
MX

Robot models

Specifications remain vendor-claimed

Machinemedical

Magnendo Magnetic Robotic Navigation System

  • Magnetically steerable soft-robotic guidewire with robotic control and navigation software for endovascular neurovascular access; targets faster, safer access to hard-to-reach brain vessels

    Vendor-stated capability of the Magnendo platform for stroke intervention and aneurysm treatment

    Claim source
CA

Funding history

Publicly announced rounds

Investors on recordPenumbra
TL

Company timeline

Milestones and announcements

2026-07-24$18M Series A closed led by Penumbra to advance robotic platform and prepare for first-in-human clinical studiesBioSpace
SC

Source ledger

1 unique public sources